Art

J-GLOBAL ID：200902294111606299   Reference number：03A0748462

Synthesis of Glycosylcurcuminoids

グリコシルクルクミノイドの合成

Author (7)： MOHRI K (Showa Pharmaceutical Univ., Tokyo, JPN) ,  WATANABE Y (Showa Pharmaceutical Univ., Tokyo, JPN) ,  YOSHIDA Y (Showa Pharmaceutical Univ., Tokyo, JPN) ,  SATOH M (Showa Pharmaceutical Univ., Tokyo, JPN) ,  ISOBE K (Showa Pharmaceutical Univ., Tokyo, JPN) ,  SUGIMOTO N (National Inst. of Health Sci., Tokyo, JPN) ,  TSUDA Y (Univ. Karachi, Karachi, PAK)
Material： Chemical and Pharmaceutical Bulletin  (Chemical & Pharmaceutical Bulletin)
Volume： 51  Issue： 11  Page： 1268-1272  Publication year： Nov. 01, 2003 
JST Material Number： G0504A  ISSN： 0009-2363  CODEN： CPBTAL  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *glucoside ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=03A0748462&from=J-GLOBAL&jstjournalNo=G0504A") }}

JST classification (1)： Glycosides  (CF10057O)

Substance index (22)： Curcumin ,  Demethoxycurcumin ,  Bisdemethoxycurcumin ,  Curcumin4,4′-O-β-D-diglucoside ,  Curcumin4′-O-β-D-glucoside ,  Vanillin ,  4-Hydroxybenzaldehyde ,  1-O-(2-Methoxy-4-formylphenyl)-β-D-glucopyranose 2,3,4,6-tetraacetate ,  4-Formylphenyl 2-O,3-O,4-O,6-O-tetraacetyl-β-D-glucopyranoside ,  3-Methoxy-4-(2-O,3-O,4-O,6-O-tetraacetyl-β-D-galactopyranosyloxy)benzaldehyde ,  Tri-sec-butylborane ,  (1E,6E)-1,7-Bis[3-methoxy-4-(2-O,3-O,4-O,6-O-tetraacetyl-β-D-glucopyranosyloxy)phenyl]-1,6-heptadiene-3,5-dione ,  (1E,6E)-1-[3-Methoxy-4-(2-O,3-O,4-O,6-O-tetraacetyl-β-D-glucopyranosyloxy)phenyl]-7-(3-methoxy-4-hydroxyphenyl)-1,6-heptadiene-3,5-dione ,  (1E,6E)-1,7-Bis[4-(2-O,3-O,4-O,6-O-tetraacetyl-β-D-glucopyranosyloxy)phenyl]-1,6-heptadiene-3,5-dione ,  (1E,6E)-1-[4-(2-O,3-O,4-O,6-O-Tetraacetyl-β-D-glucopyranosyloxy)phenyl]-7-(3-methoxy-4-hydroxyphenyl)-1,6-heptadiene-3,5-dione ,  (1E,6E)-1,7-Bis[3-methoxy-4-(2-O,3-O,4-O,6-O-tetraacetyl-β-D-galactopyranosyloxy)phenyl]-1,6-heptadiene-3,5-dione ,  (1E,6E)-1-[3-Methoxy-4-(2-O,3-O,4-O,6-O-tetraacetyl-β-D-galactopyranosyloxy)phenyl]-7-(3-methoxy-4-hydroxyphenyl)-1,6-heptadiene-3,5-dione ,  (1E,6E)-1,7-Bis[4-(β-D-glucopyranosyloxy)phenyl]-1,6-heptadiene-3,5-dione ,  (1E,6E)-1-[4-(β-D-Glucopyranosyloxy)phenyl]-7-(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione ,  (1E,6E)-1,7-Bis[3-methoxy-4-(β-D-galactopyranosyloxy)phenyl]-1,6-heptadiene-3,5-dione ,  (1E,6E)-1-[3-Methoxy-4-(β-D-galactopyranosyloxy)phenyl]-7-(3-methoxy-4-hydroxyphenyl)-1,6-heptadiene-3,5-dione ,  (4Z)-1,7-Bis[3-methoxy-4-(β-D-glucopyranosyloxy)phenyl]-5-hydroxy-4-heptene-3-one

Reference (18)：

• 1) Sreejayan Rao M. N. A., J. Pharm. Pharmacol., 46, 1013—1016 (1994).
• 2) Srimal R. C., Dhawan B. N., J. Pharm. Pharmacol., 25, 447—452 (1973).
• 3) Rao D. S., Sekhara N. C., Satyanarayana M. N., Srinivasan M., J. Nutr., 100, 1307—1316 (1970).
• 4) Babu P. S., Srinivasan K., Mol. Cell. Biochem., 166, 169—175 (1997).
• 5) Samaha H. S., Kelloff G. J., Steele V., Rao C. V., Reddy B. S., Cancer Res., 57, 1301—1305 (1997).